Brochure | October 14, 2026

Scaling Difficult Chemistry Without Site Transfers: Inside Curia Origgio

Source: Curia
Modern Medical Laboratory, biotechnology research-GettyImages-2266784532
After strategy, integration, and technology have shaped the supply plan, execution shifts to the final mile: the clinical site, where planning assumptions meet site‑level realities.

Scale-up is rarely a matter of moving the same reaction into a larger vessel, and the gap widens for cryogenic, organometallic, high-pressure and transition-metal-catalyzed steps. This look at a GMP site in Origgio, Italy centers on a practical evaluation question for CMC and external-manufacturing teams: can a proposed site run the hardest step in the route at the scale the program will eventually need? It covers the site's reactor range, its volume of low-temperature work, its hydrogenation capacity and catalyst handling, and what staying at one site does and does not change for development, validation and change control. It also addresses site history and inspection record.

Explore the site profile to see how the specifics hold up against your own route requirements.

Access The Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online